Abstract
Background
Local resection, including endoscopic resection, is recommended for rectal neuroendocrine tumors (NETs) < 15 mm in patients without risk factors for metastasis, though the short- and long-term outcomes are unclear.
Aims
This study investigates the efficacy of endoscopic resection for rectal NETs < 15 mm.
Methods
The short- and long-term outcomes of patients with rectal NETs < 15 mm who underwent endoscopic resection and the outcomes of each endoscopic technique were analyzed. The tumors were stratified as < 10 mm (small-size group, SSG) and 10–14 mm (intermediate-size group, IMG).
Results
Overall, 139 lesions (SSG, n = 118; IMG, n = 21) were analyzed. All tumors were classified as G1 (n = 135) or G2 (n = 4) according to the 2019 World Health Organization grading criteria. The complete resection rate was not different between the groups (P = 0.151). Endoscopic submucosal dissection (ESD) and endoscopic submucosal resection with a ligation device (ESMR-L) achieved complete resection rates > 90% in the SSG. The ESMR-L procedure time (P < 0.001) and hospitalized period (P < 0.001) were significantly shorter than those of ESD. ESD achieved a complete resection rate of 80.0% in the IMG. The tumor size did not affect the overall survival or rate of lymph node/distant metastases.
Conclusions
Endoscopic resection is a feasible and effective treatment for patients with rectal NETs < 15 mm without the risk factors of metastasis. ESMR-L and ESD are optimal techniques for resecting tumors smaller than 10 mm and 10–14 mm, respectively.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding authors.
References
Gallo C, Rossi RE, Cavalcoli F et al. Rectal neuroendocrine tumors: current advances in management, treatment, and surveillance. World J Gastroenterol. 2022;28:1123–1138.
Osagiede O, Habermann E, Day C et al. Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections. J Gastrointest Oncol. 2020;11:836–846.
Wang XY, Chai NL, Linghu EQ et al. Efficacy and safety of hybrid endoscopic submucosal dissection compared with endoscopic submucosal dissection for rectal neuroendocrine tumors and risk factors associated with incomplete endoscopic resection. Ann Transl Med. 2020;8:368.
Ploeckinger U, Kloeppel G, Wiedenmann B et al. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology. 2009;90:349–363.
Dasari A, Shen C, Halperin D et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–1342.
Chang JS, Chen LT, Shan YS et al. An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan. Sci Rep. 2021;11:7881.
Scherübl H, Cadiot G. Early gastroenteropancreatic neuroendocrine tumors: endoscopic therapy and surveillance. Visc Med. 2017;33:332–338.
Basuroy R, O’Donnell CM, Srirajaskanthan R et al. Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme. Colorectal Dis. 2018;20:O85–O91.
Dąbkowski K, Szczepkowski M, Kos-Kudła B et al. Endoscopic management of rectal neuroendocrine tumours. How to avoid a mistake and what to do when one is made? Endokrynol Pol 2020;71:343–349.
Chen HT, Xu GQ, Teng XD et al. Diagnostic accuracy of endoscopic ultrasonography for rectal neuroendocrine neoplasms. World J Gastroenterol. 2014;20:10470–10477.
Ngamruengphong S, Kamal A, Akshintala V et al. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors. Gastrointest Endosc. 2019;89:602–606.
Kuiper T, van Oijen MGH, van Velthuysen MF et al. Endoscopically removed rectal NETs: a nationwide cohort study. Int J Colorectal Dis. 2021;36:535–541.
Matsuhashi N, Takahashi T, Tomita H et al. Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines. Mol Clin Oncol. 2017;7:476–480.
Ito T, Masui T, Komoto I et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021;56:1033–1044.
Kunz PL, Reidy-Lagunes D, Anthony LB et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013;42:557–577.
Ramage JK, De Herder WW, Delle Fave G et al. ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:139–143.
Kulke MH, Shah MH, Benson AB 3rd et al. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw. 2015;13:78–108.
Park CH, Cheon JH, Kim JO et al. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. Endoscopy. 2011;43:790–795.
de Mestier L, Brixi H, Gincul R et al. Updating the management of patients with rectal neuroendocrine tumors. Endoscopy. 2013;45:1039–1046.
Chida K, Watanabe J, Hirasawa K et al. A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors. Ann Gastroenterol Surg. 2020;4:562–570.
Zheng X, Wu M, Er L et al. Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours. Int J Colorectal Dis. 2022;37:421–428.
Rossi RE, Elvevi A, Gallo C et al. Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are. World J Gastroenterol. 2022;28:3258–3273.
Hamada Y, Tanaka K, Tano S et al. Usefulness of endoscopic submucosal dissection for the treatment of rectal carcinoid tumors. Eur J Gastroenterol Hepatol. 2012;24:770–774.
Chen T, Yao LQ, Xu MD et al. Efficacy and safety of endoscopic submucosal dissection for colorectal carcinoids. Clin Gastroenterol Hepatol. 2016;14:575–581.
Lim HK, Lee SJ, Baek DH et al. Resectability of rectal neuroendocrine tumors using endoscopic mucosal resection with a ligation band device and endoscopic submucosal dissection. Gastroenterol Res Pract. 2019;2019:8425157.
Takita M, Sakai E, Nakao T et al. Clinical outcomes of patients with small rectal neuroendocrine tumors treated using endoscopic submucosal resection with a ligation device. Digestion 2019;99:72–78.
Park SB, Kim HW, Kang DH et al. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors. World J Gastroenterol. 2015;21:9387–9393.
Nagai T, Torishima R, Nakashima H et al. Saline-assisted endoscopic resection of rectal carcinoids: cap aspiration method versus simple snare resection. Endoscopy. 2004;36:202–205.
Chen R, Liu X, Sun S et al. Comparison of endoscopic mucosal resection with circumferential incision and endoscopic submucosal dissection for rectal carcinoid tumor. Surg Laparosc Endosc Percutan Tech. 2016;26:e56-61.
Zhang J, Liu M, Li H et al. Comparison of endoscopic therapies for rectal carcinoid tumors: Endoscopic mucosal resection with circumferential incision versus endoscopic submucosal dissection. Clin Res Hepatol Gastroenterol. 2018;42:24–30.
Meier B, Albrecht H, Wiedbrauck T et al. Full-thickness resection of neuroendocrine tumors in the rectum. Endoscopy. 2020;52:68–72.
Zhou X, **e H, **e L et al. Endoscopic resection therapies for rectal neuroendocrine tumors: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2014;29:259–268.
Hamada Y, Tanaka K, Hattori A et al. Clinical utility of endoscopic submucosal dissection using the pocket-creation method with a HookKnife and preoperative evaluation by endoscopic ultrasonography for the treatment of rectal neuroendocrine tumors. Surg Endosc. 2022;36:375–384.
Mashimo Y, Matsuda T, Uraoka T et al. Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum. J Gastroenterol Hepatol. 2008;23:218–221.
Kim HH, Park SJ, Lee SH et al. Efficacy of endoscopic submucosal resection with a ligation device for removing small rectal carcinoid tumor compared with endoscopic mucosal resection: analysis of 100 cases. Dig Endosc. 2012;24:159–163.
Park SS, Kim BC, Lee DE et al. Comparison of endoscopic submucosal dissection and transanal endoscopic microsurgery for T1 rectal neuroendocrine tumors: a propensity score-matched study. Gastrointest Endosc. 2021;94:408-415.e402.
Brand M, Reimer S, Reibetanz J et al. Endoscopic full thickness resection vs. transanal endoscopic microsurgery for local treatment of rectal neuroendocrine tumors—a retrospective analysis. Int J Colorectal Dis. 2021;36:971–976.
Acknowledgments
The authors thank the medical staff members of the Department of Endoscopy at each participating hospital for their contributions to this study. We also thank Editage (www.editage.com) for their English language editing.
Funding
The authors did not receive any funding relevant to this article.
Author information
Authors and Affiliations
Contributions
YH and KT designed the study; collected, analyzed, and interpreted the data; and drafted the manuscript. KM, YB, MK, ST, HK, SS, MK, SS, and HI collected the data. MM evaluated the pathological findings. ST provided guidance regarding the study design. HN supervised the study. All authors have reviewed the manuscript and approved the final draft.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethical approval
The study was approved by the Ethics Committee of Mie University Hospital on March 17, 2021 (approval number: H2020-185) and registered in the University Hospital Medical Network Clinical Trials Registration (UMIN000043210). The study was conducted in accordance with the approved protocol and ethical standards of the Declaration of Helsinki of 1964 and later amendments. Informed consent was obtained from the patients using the opt-out method.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-07927-z.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hamada, Y., Tanaka, K., Mukai, K. et al. Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm. Dig Dis Sci 68, 3148–3157 (2023). https://doi.org/10.1007/s10620-023-07914-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-07914-4